stock decline

REGENXBIO faces securities lawsuit for allegedly misleading investors about RGX-111 gene therapy safety concerns. FDA imposed clinical hold after trial participant developed CNS tumor.

Snap's CTO sold $10.6M in shares as stock hits all-time low of $4.72, amid weak revenue guidance and continued losses in competitive ad market.

Booking Holdings' stock fell 27% amid competition, but the company is pursuing AI integration and expanding its bundled travel services to drive growth and improve efficiency.

F5 faces class action lawsuit over undisclosed BIG-IP security breach. Stock plunged 10.9% after October disclosure; shareholders sought for litigation by February 17 deadline.

Fermi Inc. faces securities lawsuit after major tenant canceled $150M funding deal, causing 52% stock decline. Investors must file claims by March 6.

Hub Group restates financials after discovering $77M accounting error in transportation costs. Stock dropped 25%, though cash flow unaffected.

Klarna faces securities lawsuit alleging IPO misstatements about loan loss reserves. Investors have until February 20 to join class action.

Wealthfront's stock plummets 26% after disappointing earnings. Legal investigation launched over weak asset inflows and CEO conflict-of-interest concerns regarding banking partner stake.

Aquestive Therapeutics' stock plunged 40% after FDA cited major deficiencies in its Anaphylm anaphylaxis treatment application. Shareholder lawsuit investigation underway over disclosure adequacy.

Major institutional investors like ARK Invest and BlackRock are buying Roblox shares despite a 52% stock decline, signaling potential confidence in recovery prospects.

Hub Group to restate 2025 financial results due to accounting errors in transportation costs and payables, causing 24% stock decline and triggering potential shareholder litigation.

SoundHound AI stock down 65% to below $8 amid $109M operating losses. Company targets profitability in 2026 while expanding voice AI platform across industries.

Major investor Black Creek liquidated $32.75M in NICE Systems shares despite strong operational performance, including 49% AI revenue growth and 6% overall revenue expansion.

Helix Partners exits entire Sallie Mae stake amid rising loan delinquencies and credit headwinds at the student loan servicer, which underperformed the market by 27.5 percentage points.

Cinemark launches $300M buyback and receives $7M investment from Helix Partners, signaling confidence despite 21% annual stock decline and strong operational metrics.

Kyndryl faces securities fraud investigation after disclosing audit review of cash management and internal controls. Stock fell 50%; class action deadline set for April 13.

Richtech Robotics faces securities lawsuit over false Microsoft partnership claims. Stock fell 20.87% after critical report questioned the deal's legitimacy.

AGL faces securities fraud allegations over false 2025 guidance. Stock plunged 51.5% after guidance suspension; investors have until March 2026 deadline to join class action.

BellRing Brands faces securities lawsuit over allegedly false statements about sales growth. Investors have until March 23 to join the class action suit.

Law firm sues REGENXBIO for allegedly hiding safety concerns about gene therapy RGX-111. Stock dropped 17.8% after FDA clinical hold due to tumor in trial participant.